After majoring in internal medicine, Dr Peter Galle received an MD from Marburg University and a PhD from Heidelberg University, where he was a postdoctoral fellow at the Centre for Molecular Biology. He completed his residency in internal medicine and gastroenterology at the University Hospital of Heidelberg and, in 1998, became Director of the Internal Medicine Department in Mainz. He was CEO of Mainz University Hospital from 2005–2008.
Dr Galle is a member of several societies, including the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver (EASL). He has served as Executive Board Member and President of the International Liver Cancer Association, and Congress President of the German Society for Digestive Diseases. Dr Galle is 2020 President-elect of the German Association for the Study of the Liver.
Dr Galle’s research has focused on apoptotic cell death in the liver, immune escape of tumor cells, and clinical and molecular aspects of HCC. He has published more than 500 peer-reviewed papers, and was awarded several prizes, including the prestigious Tannhauser award. Dr Galle chaired the panel updating the 2018 EASL Clinical Practice Guideline on HCC and has served as Co-editor for the Journal of Hepatology.